Medicare Enrolled

Dr. David K Ornstein, MD

Urology Physician · Naples, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
733 4TH AVE N, Naples, FL 34102
2394039503
In practice since 2006 (19 years)
NPI: 1285714428 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ornstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ornstein? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ornstein

Dr. David K Ornstein is an urology physician in Naples, FL, with 19 years in practice. Based on federal Medicare data, Dr. Ornstein performed 6,493 Medicare services across 1,461 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ornstein received a total of $18,316 from 36 pharmaceutical and/or device companies across 131 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ornstein is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 19% volume in FL$ $18,316 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,493
Medicare services
Top 19% in FL for urology physician
1,461
Unique beneficiaries
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~342 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
BCG treatment for bladder cancer4,205$2$9
Office visit, established patient (20-29 min)617$68$226
Automated urinalysis307$2$10
Diagnostic exam of bladder and urethra using an endoscope269$188$705
Office visit, established patient (10-19 min)177$44$136
Injection, mitomycin, 5 mg160$40$197
Instillation of anti-cancer drug into bladder109$71$382
Office visit, established patient (30-39 min)101$102$335
Telephone medical discussion with physician, 5-10 minutes90$44$198
New patient office visit (45-59 min)89$131$526
Leuprolide acetate (for depot suspension), 7.5 mg86$135$684
New patient office visit (30-44 min)44$83$342
Surgical removal of prostate and surrounding lymph nodes using an endoscope40$1,015$6,006
Removal of lymph nodes of both sides of pelvis using an endoscope34$283$2,734
Destruction and/or removal of large growth of bladder using an endoscope25$322$1,753
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle24$27$113
Ultrasonic guidance during surgery20$54$236
Partial removal of kidney using an endoscope19$1,258$5,159
Insertion of stent in ureter using an endoscope15$94$1,600
Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope14$254$839
Removal of kidney and lymph nodes using an endoscope13$1,043$4,665
Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm13$234$1,003
Biopsy of prostate gland11$110$481
Ultrasound scan of pelvic region through rectum11$26$120
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.8% high complexity
3.2% medium
96.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$18,316
Total received (2018-2024)
Avg $2,617/year across 7 years
Top 12% in FL for urology physician
36
Companies
131
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14,348 (78.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,968 (21.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,001
2023
$10,782
2022
$1,008
2021
$332
2020
$193
2019
$302
2018
$697

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Intuitive Surgical, Inc.
$10,531
INTUITIVE SURGICAL, INC.
$4,410
PROCEPT BioRobotics Corporation
$457
Janssen Biotech, Inc.
$347
UroGen Pharma, Inc.
$317
Myriad Genetic Laboratories, Inc.
$307
Janssen Scientific Affairs, LLC
$293
PFIZER INC.
$201
Blue Earth Diagnostics Limited
$189
Bayer HealthCare Pharmaceuticals Inc.
$148
Astellas Pharma US Inc
$147
Augmenix, Inc.
$137
GENZYME CORPORATION
$125
UROGEN PHARMA, INC.
$93
Ferring Pharmaceuticals Inc.
$89
Photocure Inc
$54
Kerecis Limited
$44
Coloplast Corp
$42
Boston Scientific Corporation
$42
Sumitomo Pharma America, Inc.
$39
Verity Pharmaceuticals Inc.
$30
ABBVIE INC.
$27
NeoTract Inc.
$26
TOLMAR Pharmaceuticals, Inc.
$24
Ethicon US, LLC
$23
Laborie Medical Technologies Corp.
$22
IMMUNITYBIO, INC.
$21
ROCHESTER MEDICAL CORPORATION
$20
Smith+Nephew, Inc.
$18
Kowa Pharmaceuticals America, Inc.
$17
AngioDynamics, Inc.
$16
Dendreon Pharmaceuticals LLC
$13
Novartis Pharmaceuticals Corporation
$13
Endo Pharmaceuticals Inc.
$12
NxThera, Inc.
$11
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 84.1% of total payments
Associated products mentioned in payments ›
ADSTILADRIN · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Axumin · BRACAnalysis CDx · Cysview · DA VINCI SP · Da Vinci Surgical System · ELIGARD · ERLEADA · Enseal X1 5mm · Erleada · GEMTESA · GENERAL BPH · JELMYTO · JEVTANA · Kerecis Omega3 SurgiClose · LUPRON DEPOT · MEKINIST · MYRISK · NANOKNIFE · Nubeqa · ORGOVYX · POSLUMA · PROLARIS · PROVENGE · Prolaris · REZUM · Rezum · SEGLENTIS · SUTENT · SpaceOAR · SpeediCath · Stravix · Trelstar · UroLift · XTANDI · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (78%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $282 per 100 Medicare services performed
Looking for a urology physician in Naples?
Compare urology physicians in the Naples area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
22
Per 100K population
5.7
County median income
$86,173
Nearest hospital
NAPLES COMMUNITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ornstein is a clinical cardiology specialist, with above-average Medicare volume (top 19% in FL), and high industry engagement (speaking/promotional, top 12%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ornstein experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Ornstein performed 4,205 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ornstein receive payments from pharmaceutical companies?
Yes. Dr. Ornstein received a total of $18,316 from 36 companies across 131 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ornstein's costs compare to other urology physicians in Naples?
Dr. Ornstein's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ornstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →